Leonora Barclay
2025.12.03
48% relevant
Both concern advances in reproductive/biotech that change family and kinship norms and trigger legal and ethical debates about parentage, oversight, and commercialization; pet cloning’s scaling (Colossal/Viagen, price points) is a proximate example of how reproductive biotechs move from lab to market, echoing themes in the existing idea.